Viewing data from:

SULFASALAZINE

ANDA

SULFASALAZINE | A080197 | CHARTWELL PHARMA SCIENCE LLC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: AZULFIDINE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.1975

per ea

Lowest NADAC/Unit

$0.1975

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62135096001SULFASALAZINE 500 MG TABLET	$0.1975	EA	Generic	—	2026-06-17
62135096005SULFASALAZINE 500 MG TABLET	$0.1975	EA	Generic	—	2026-06-17
62135096010SULFASALAZINE 500 MG TABLET	$0.1975	EA	Generic	—	2026-06-17
62135096031SULFASALAZINE 500 MG TABLET	$0.1975	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain3 active DMFs6 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CAMBREX CHARLES CITY INCSULFASALAZINE USP

DMF 22391974

VALENS MOLECULES PRIVATE LTDSULFASALAZINE USP

DMF 261272012

CAMBREX CHARLES CITY INCSULFASALAZINE, PURIFIED

DMF 419262025

ACF CHEMIEFARMA NVInactiveSULFASALAZINE

DMF 64891986

IFP INCInactiveSULFASALAZINE STARCH POWDER

DMF 71271987

CORDEN PHARMA BERGAMO SPAInactiveSULFASALAZINE

DMF 111631994

SALSBURY CHEMICALS INCInactiveSULFASALAZINE PVP

DMF 146882000

ZHEJIANG JIUZHOU PHARMACEUTICAL CO LTDInactiveSULFASALAZINE

DMF 147242000

SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTDInactiveSULFASALAZINE

DMF 222382008

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 500MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.